Sitagliptin (Januvia)
Showing 1 - 25 of 340
Polycystic Ovary Syndrome Trial in Bani Suwayf (Sitagliptin 100mg)
Not yet recruiting
- Polycystic Ovary Syndrome
- Sitagliptin 100mg
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Aug 1, 2023
Type 2 Diabetes Trial in Buffalo (Januvia (Sitagliptin) 100 mg, Placebo)
Completed
- Type 2 Diabetes
- Januvia (Sitagliptin) 100 mg
- Placebo
-
Buffalo, New York115 Flint Road
Feb 2, 2022
Diabetes, Type 2 Diabetes Trial (Sitagliptin, Metformin, Placebo to sitagliptin)
Healthy Volunteers (Intended Indication: Type 2 Diabetes) Trial in Berlin (Dapagliflozin/sitagliptin FDC, Sitagliptin,
Completed
- Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
- Dapagliflozin/sitagliptin FDC
- +2 more
-
Berlin, GermanyResearch Site
Jun 30, 2022
Type 2 Diabetes Trial in Mexico City (Sitagliptin 100mg, Glargine, Lispro)
Recruiting
- Type 2 Diabetes
- Sitagliptin 100mg
- +2 more
-
Mexico City, MexicoDivisión de Investigación en Salud, Hospital de Especialidades,
Oct 11, 2022
Pre-diabetes, Type 2 Diabetes Trial in Philadelphia (Exenatide, Sitagliptin, Glimepiride)
Completed
- Pre-diabetes
- Type 2 Diabetes
- Exenatide
- +2 more
-
Philadelphia, Pennsylvania
- +2 more
May 16, 2022
Immune Thrombocytopenia, Blood Coagulation Disorders, Thrombocytopenia Trial in Beijing (Sitagliptin, Danazol)
Recruiting
- Immune Thrombocytopenia
- +3 more
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Apr 25, 2022
Genetics Disease, Type2 Diabetes, Heart Failure Trial in Philadelphia (Sitagliptin 100mg, Placebo Oral Tablet)
Recruiting
- Genetics Disease
- +2 more
- Sitagliptin 100mg
- Placebo Oral Tablet
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 30, 2021
Type 2 Diabetes Trial (metformin and sitagliptin, insulin glargine and insulin lispro)
Withdrawn
- Type 2 Diabetes Mellitus
- metformin and sitagliptin
- insulin glargine and insulin lispro
- (no location specified)
Oct 4, 2021
Type 2 Diabetes Trial (Sitagliptin, Placebo)
Type 2 Diabetes Trial in Seongnam (Sitagliptin, Dapagliflozin, Lobeglitazone)
Completed
- Type 2 Diabetes
- Sitagliptin
- +4 more
-
Seongnam, Gyeonggi, Korea, Republic ofSoo Lim
Jan 2, 2022
Cystic Fibrosis, Pancreatic Insufficiency Trial in Philadelphia (Sitagliptin, Placebo)
Completed
- Cystic Fibrosis
- Pancreatic Insufficiency
- Sitagliptin
- Placebo
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia and University of Pennsylvan
Feb 24, 2022
Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)
Completed
- Type 2 Diabetes Mellitus
- Hypertension
- Placebo
- +3 more
-
Nashville, TennesseeVanderbilt University
Feb 8, 2022
Polycystic Ovary Syndrome, Infertility, ART Trial in Tehran (, metformin, Sitagliptin)
Recruiting
- Polycystic Ovary Syndrome
- +2 more
- placebo
- +3 more
-
Tehran, Iran, Islamic Republic ofMahdiyeh educational hospital
Mar 19, 2021
Type 2 Diabetes, Ketonemia Trial in Hong Kong (Dapagliflozin 10 mg, Sitagliptin 100mg)
Completed
- Type 2 Diabetes
- Ketonemia
- Dapagliflozin 10 mg
- Sitagliptin 100mg
-
Hong Kong, Hong KongL2 Diabetes Centre, Queen Mary Hospital
Apr 28, 2021
Diabetes Type 2 Trial in Doha (Metformin, Gliclazide, Sitagliptin)
Active, not recruiting
- Diabetes Mellitus Type 2
- Metformin
- +6 more
-
Doha, QatarHamad Medical Corporation
Apr 27, 2022
Graft Vs Host Disease Trial in Petach Tikva (Sitagliptin 100mg)
Unknown status
- Graft Vs Host Disease
- Sitagliptin 100mg
-
Petach Tikva, IsraelRabin Medical Center
Jan 29, 2021
Type 2 Diabetes Trial in Seongnam (Ipragliflozin, Sitagliptin)
Recruiting
- Type 2 Diabetes Mellitus
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Mar 29, 2021
Obesity Trial in Aurora (Sitagliptin Phosphate)
Completed
- Obesity
- Sitagliptin Phosphate
-
Aurora, ColoradoUniversity of Colorado Denver
Mar 9, 2021
Type 2 Diabetes Trial in Dundee (Sulfonylurea, DPP4 Inhibitor)
Completed
- Type 2 Diabetes
- Sulfonylurea
- DPP4 Inhibitor
-
Dundee, United KingdomNinewells Hospital and Medical School
Mar 3, 2021
Diabetes Type 1, Diabetes Type 2 Trial run by the NIDDK (Sitagliptin (Januvia))
Completed
- Diabetes Mellitus Type 1
- Diabetes Mellitus Type 2
- Sitagliptin (Januvia)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 27, 2019
Type 2 Diabetes, Heart Failure Trial in Worldwide (Saxagliptin, Sitagliptin, Placebo to match saxagliptin)
Completed
- Type 2 Diabetes Mellitus
- Heart Failure
- Saxagliptin
- +3 more
-
Torrance, California
- +73 more
Nov 5, 2021
Type 2 Diabetes Trial in Exeter (Sitagliptin - DPP4i, Canagliflozin - SGLT2i, Pioglitazone - TZD)
Completed
- Type 2 Diabetes
- Sitagliptin - DPP4i
- +2 more
-
Exeter, United KingdomExeter Clinical Research Facility
Mar 30, 2021